Status:
UNKNOWN
Omarigliptin in Four Healthy Egyptian Volunteers
Lead Sponsor:
British University In Egypt
Conditions:
Healthy Volunteers
Eligibility:
All Genders
23-37 years
Phase:
NA
Brief Summary
The proposed study will consider the LC-MS/MS quantitative determination of Omarigliptin after administration to four Egyptian volunteers. The main aim of the study is to confirm that the developed LC...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Must be able to swallow tablets
Exclusion
- Insulin dependent diabetes
- Type-2 diabetes
- Hospitalized within 1 week
Key Trial Info
Start Date :
March 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 28 2020
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04365907
Start Date
March 11 2020
End Date
May 28 2020
Last Update
April 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The British University in Egypt
Cairo, El-Sherouk, Egypt, 11837